Daurismo 25 mg/1

Daurismo 25 mg is a medication used for specific therapeutic purposes. It contains the active ingredient glasdegib and is available in film-coated tablet form.

Daurismo 25 mg is primarily used in the management of certain conditions related to cell growth and differentiation. It is often prescribed for patients who require targeted therapy to inhibit abnormal cell proliferation. The medication works by interfering with specific pathways involved in cell development, making it useful in conditions where uncontrolled cell growth is a concern.

Common effects of Daurismo 25 mg may include gastrointestinal discomfort, fatigue, and changes in blood cell counts. Some individuals might experience muscle spasms or elevated liver enzymes. It is important to monitor for any unusual symptoms and consult a healthcare provider if significant side effects occur.

Daurismo 25 mg should be handled with care, following the prescribed dosage and administration guidelines. It is essential to inform healthcare providers about any pre-existing conditions or medications being taken to avoid potential complications. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Daurismo 25 mg may interact with certain medications, including those that affect liver enzymes or other drugs metabolized through similar pathways. It is advisable to avoid alcohol and consult a healthcare provider before taking any new medications while on Daurismo. Always follow the advice of a healthcare professional regarding potential drug interactions.